1. Home
  2. CANF vs UGRO Comparison

CANF vs UGRO Comparison

Compare CANF & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$3.72

Market Cap

6.2M

Sector

Health Care

ML Signal

N/A

Logo urban-gro Inc.

UGRO

urban-gro Inc.

N/A

Current Price

$3.16

Market Cap

1.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
CANF
UGRO
Founded
1994
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
1.8M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
CANF
UGRO
Price
$3.72
$3.16
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9,750.00
N/A
AVG Volume (30 Days)
631.0K
62.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,008,850.00
Revenue This Year
$461.72
$98.41
Revenue Next Year
$290,391.28
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.11
52 Week High
$10.40
$4.50

Technical Indicators

Market Signals
Indicator
CANF
UGRO
Relative Strength Index (RSI) 42.00 67.65
Support Level $0.60 $0.28
Resistance Level $4.74 $4.50
Average True Range (ATR) 0.71 0.25
MACD -0.17 -0.04
Stochastic Oscillator 0.40 76.49

Price Performance

Historical Comparison
CANF
UGRO

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: